1752 — Nang Kuang Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Nang Kuang Pharmaceutical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	418	403	378	303	351
Net Total Accounts Receivable
Net Total Receivables	351	387	376	423	365
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,491	1,640	1,538	1,456	1,493
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,699	1,624	1,950	2,169	2,162
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,429	3,585	3,856	3,813	3,823
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,073	1,040	1,283	1,143	1,065
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,189	1,174	1,479	1,391	1,339
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,240	2,411	2,377	2,422	2,484
Total Liabilities & Shareholders' Equity	3,429	3,585	3,856	3,813	3,823
Total Common Shares Outstanding